NeurologyLive | Direct Access to Expert Insight in Neurology

Clinical Focus

Quick Links

Publications

Current Issue

Alzheimer Disease Symptoms: More Than Memory Loss and Confusion

New Era Arrives for Disease Modification in Multiple Sclerosis

Searching for Off-Time Relief in Parkinson Disease

Exploring CB1, CB2 in Various Neurological Conditions

Phase III Study Brings Hope to ALS

Rapid Development of Migraine Therapies Offers New Hope

Findings from Jordana Hughes, MD

Disease-Modifying Therapies Possibly More Beneficial for Relapsed Progressive MS

A new analysis has suggested that an inflammatory response may be a crucial and modifiable determinant of disability accrual in progressive-onset multiple sclerosis.

Multiple Sclerosis: Revisions to the McDonald Criteria

Clyde E. Markowitz, MD, and Patricia K. Coyle, MD, provide insight on the 2017 revisions to the McDonald criteria that will optimize the management of patients with multiple sclerosis.

WVE-210201 Shows Potential in Early Phase Assessments for Duchenne Muscular Dystrophy

The chief medical officer of Wave Life Sciences provided insight into the investigational DMD treatment.

Galcanezumab, a Potential Treatment Option for Cluster Headache

The Senior Medical Director at Eli Lilly discussed the clinical impact galcanezumab could have for patients with cluster headache if approved by the FDA.

Phase 2 Study Reveals Positives for Zilucoplan in the Treatment of Myasthenia Gravis

The therapy met both primary and secondary end points across a broad spectrum of patients with generalized myasthenia gravis, including significant reductions in both QMG and MG-ADL scores.

Imad Najm, MD: Deep Brain Stimulation and Epilepsy

Hillary Thomas, PhD: Screening Patients With Epilepsy for Depression

Joseph Sirven, MD: Variables Impacting Vehicle Use for Patients with Epilepsy